The powerful LDL-lowering agents aren t being used to their fullest potential, but giving them early to STEMI patients along with high-intensity statins would help amend that, researchers say.
Canada: Early supplementation of PCSK9 inhibitor along with high-intensity statin further decreases LDL cholesterol (by 22%) in patients undergoing PCI for ST-segment elevation MI (STEMI), says a.
The consensus addresses current gaps in recommendations on the role of cardiac CT in the guidance of care in patients with cancer as well as survivors.